Description
FORMA FARMACÉUTICA: 20 TABLETAS MASTICABLES
Artritis psoriásica y espondilitis anquilosante
PRINCIPIO ACTIVO: LINAGLIPTINA
No indicado en pacientes con hipersensibilidad conocida al Omalizumab o a los excipientes
PRINCIPIO ACTIVO: LACTULOSA
TRIMETRO/SULFAM SUSP 120ML LGEN DERMATOLOGICOS FORMA FARMACÉUTICA: 20 TABLETAS MASTICABLESSUSTANCIA: SULFAWAL SUSP. 40 200 MG. CAJA C FCO. C 120 ML. FABRICANTE: NOVAG INFANCIA
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
You may also like
recommand products
